Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

Stocks to Buy or Sell. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against ...

Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) yesterday and set a price ...

Cardinal Health prepares to enter ... at-home healthcare supply business from the former medical segment, renamed Global Medical Products and Distribution; and the $1.2 billion unit manufacturing ...

The company said the new DC will support its at-Home Solutions business and improve the delivery of medical supplies to ...

In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been ...

In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe ...

GI Alliance is a gastroenterology management services organization, and Advanced Diabetes Supply Group is a diabetic medical supplies provider. Cardinal Health's pharmaceutical and specialty ...